CLINICAL STUDIES
Retrograde nontransseptal balloon mitral valvuloplasty: immediate results and intermediate long-term outcome in 441 casesa multicenter experience
Christodoulos I. Stefanadis, MD, FACC*,
Costas G. Stratos, MD*,
Spyros G. Lambrou, MD*,
Vinay Kumar Bahl, MD ,
Dennis V. Cokkinos, MD, FACC ,
Vassilios A. Voudris, MD, FACC ,
Stefanos G. Foussas, MD, FACC ,
Costas P. Tsioufis, MD* and
Pavlos K. Toutouzas, MD, FACC*
* Department of Cardiology of Athens University, Hippocration Hospital, Athens, Greece
All India Institute of Medical Sciences, New Delhi, India
Onassis Cardiac Surgery Center, Athens, Greece
Tzannio Hospital, Pireus, Greece
Manuscript received December 8, 1997;
revised manuscript received April 13, 1998,
accepted June 1, 1998.
Address for correspondence: Dr. Christodoulos Stefanadis, 9 Tepeleniou Street, Paleo Psychico 154 52, Athens, Greece
Objectives. Our aim was to present the immediate and intermediate long-term results of the application of retrograde nontransseptal balloon mitral valvuloplasty (RNBMV) in four cooperating centers from Greece and India.
Background. RNBMV is a purely transarterial method of balloon valvuloplasty, developed with the aim to avoid complications associated with transseptal catheterization. Only single-center experience with RNBMV has been previously reported.
Methods. The procedure was attempted in 441 patients with symptomatic mitral stenosis (320 women, 121 men, mean age [± SD] 44 ± 11 years, mean echocardiographic score [± SD] 7.7 ± 2.0) from 1988 to 1996. Three hundred eighty-five patients with successful immediate outcome were followed clinically for a mean [± SD] of 3.5 ± 1.9 (range, 0.59.1) years.
Results. A technically successful procedure was achieved in 388 (88%) cases. The echocardiographic score (p < 0.001), male gender (p = 0.005), preprocedural mitral regurgitation (p = 0.007) and previous surgical commissurotomy (p = 0.029) were unfavorable predictors of immediate outcome. Complications included death (0.2%), severe mitral regurgitation (3.4%) and injury of the femoral artery (1.1%). Event-free (freedom from cardiac death, mitral valve surgery, repeat valvuloplasty and NYHA class > II symptoms) survival rates (± SEM) were 100%, 96.9 ± 0.9%, 89.8 ± 1.9% and 75.5 ± 5.5% at 1, 2, 4 and 9 years, respectively. The echocardiographic score (p < 0.001), NYHA class (p = 0.008) and postprocedural mitral valve area (p = 0.009) were significant independent predictors of intermediate long-term outcome.
Conclusions. Multicenter experience indicates that RNBMV is a safe and effective technique for the treatment of symptomatic mitral stenosis. As with the transseptal approach, patients with favorable mitral valve anatomy derive the greatest immediate and intermediate long-term benefit from this procedure.
|
Abbreviations and Acronyms
| | FA | = femoral artery | | FU | = follow-up | | LA | = left atrial, left atrium | | LV | = left ventricle, left ventricular | | MR | = mitral regurgitation | | MVA | = mitral valve area | | MVR | = mitral valve replacement | | NYHA | = New York Heart Association | | RNBMV | = retrograde nontransseptal balloon mitral valvuloplasty |
|
This article has been cited by other articles:

|
 |

|
 |
 
B. Iung, A. Nicoud-Houel, O. Fondard, H. Akoudad, T. Haghighat, E. Brochet, E. Garbarz, B. Cormier, G. Baron, P. Luxereau, et al.
Temporal trends in percutaneous mitral commissurotomy over a 15-year period
Eur. Heart J.,
April 2, 2004;
25(8):
701 - 707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-W. Chiang, L.-A. Hsu, P.-H. Chu, W.-J. Ho, H.-S. Lo, and C.-C. Chang
Feasibility of Simplifying Balloon Mitral Valvuloplasty by Obviating Left-Sided Cardiac Catheterization Using On-line Guidance With Transesophageal Echocardiography
Chest,
June 1, 2003;
123(6):
1957 - 1963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Rahimtoola, A. Durairaj, A. Mehra, and I. Nuno
Current Evaluation and Management of Patients With Mitral Stenosis
Circulation,
September 3, 2002;
106(10):
1183 - 1188.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Bashore, E. R. Bates, P. B. Berger, D. A. Clark, J. T. Cusma, G. J. Dehmer, M. J. Kern, W. K. Laskey, M. P. O'Laughlin, S. Oesterle, et al.
American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on Cardiac Catheterization Laboratory Standards: A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents endorsed by the American Heart Association and the Diagnostic and Interventional Catheterization Committee of the Council on Clinical Cardiology of the AHA
J. Am. Coll. Cardiol.,
June 15, 2001;
37(8):
2170 - 2214.
[Full Text]
[PDF]
|
 |
|
|